Beverly Davidson
Has grant
Chief Scientific Strategy Officer
United StatesResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Beverly Davidson is the Chief Scientific Strategy Officer at the Children's Hospital of Philadelphia, USA. Her research focuses on gene therapy, particularly in the areas of alternative splicing, AAV vector development, and CRISPR-mediated gene editing. Recent publications include investigations into gene therapy applications for conditions such as myotonic dystrophy, spinocerebellar ataxia, and Huntington's disease, emphasizing advancements in vector safety and efficacy.
Recent Grants
Grant: Close
LMI070 Studies for Gene Therapy
Open Date: 2020-02-01
Close Date: 2023-03-01
Grant: Close
Therapeutic APOE2 overexpression for early Alzheimer's disease
Open Date: 2019-05-01
Close Date: 2022-04-30
Grant: Close
Gene Editing for SCA2 Therapy
Open Date: 2019-03-01
Close Date: 2020-02-01
Grant: Close
Unilateral Intraventricular Administration of AAV2.CAG.APOE2 in NHPs
Open Date: 2019-03-01
Close Date: 2021-01-01
Grant: Close
AAV Libraries from NHP Panning
Open Date: 2019-01-01
Close Date: 2019-12-01
Articles (13)
Year:
2025
Year:
2025
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Collaborators (2)
Terence Flotte
Dean, Provost and Executive Deputy Chancellor
University of Massachusetts Chan Medical School
Allison Bradbury
Assistant Professor
Ohio State University
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.